LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma

LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is a highly malignant tumor of the digestive system with increasing morbidity and mortality. The lack of sensitive and reliable biomarkers is one of the main reasons for the poor prognosis. Volume-regulated anion channels (VRAC), which are ubiquitously expressed in t...

Full description

Bibliographic Details
Main Authors: Rong Xu, Yaohua Hu, Qinghua Xie, Caiqin Zhang, Yong Zhao, He Zhang, Hailong Shi, Xiaoming Wang, Changhong Shi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
pancreatic adenocarcinoma (PAAD)
bioinformatics analyses
leucine-rich repeat-containing protein 8A (LRRC8A)
immune infiltration
Online Access:https://www.mdpi.com/2072-6694/14/22/5526

Internet

https://www.mdpi.com/2072-6694/14/22/5526

Similar Items